The MOSAIC Window dataset is now fully available

We’re excited to share that MOSAIC Window has now reached 60 patients — the full release of this subset from the larger MOSAIC dataset!

In this round, we’ve added data from Mesothelioma, DLBCL, and Ovarian cancer patients to complete the 5 indications:

• Ovarian (n=15)
• Mesothelioma (n=10)
• DLBCL (n=10)
• Glioblastoma (n=10)
• Bladder (n=15)

These data include all six MOSAIC modalities (spatial transcriptomics, single-cell RNA, bulk RNA, whole exome sequencing, pathology / histology, clinical metadata), and are available via the European Genome-Phenome Archive (EGA).

Researchers can apply to access MOSAIC Window via EGA and begin proof-of-concept studies enabling deeper insights into tumor-immune interactions, biomarker discovery, and more

You can also explore this data through our AI research co-pilot K Navigator

‍